![]()
ASX code: NRT
Listing Date: Thu, 1 Sep 1994
Website: http://www.novogen.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Pharmaceutical research and development and manufacturing and marketing of health supplements.
Address:
, , 140 Wicks Road,
NORTH RYDE
NSW 2113
Phone: (02) 9878 0088
Fax: (02) 9878 0055
Executives & Directors
Mr Philip A Johnston, Chairman, Non Exec. Director
Mr Christopher Naughton, Managing Director, CEO, Executive Director
Mr William D Rueckert, Director
Prof. Alan James Husband, Executive Director
Mr Geoffrey M Leppinus, Non Exec. Director
Prof. Paul J Nestel, AO, Non Exec. Director
Mr Peter B Simpson, Non Exec. Director
Mr David R Seaton, CFO
Mr Ronald L Erratt, Company Secretary
Please contact the ASX to change these details
Company Podcasts
Subscribe to current and future audio events for NRT
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
View this company's details on the Australian Securities Exchange website
NOVOGEN LIMITED (NRT) Events
NOVOGEN LIMITED (NRT)
| IDMC reviews MEIs arrangements for data analysis | Thu, 18 Jun 2009 |
| Response to ASX Query | Tue, 19 May 2009 |
| Novogen`s NV-128 targets mTOR pathway | Mon, 20 Apr 2009 |
| Marshall Edwards to analyse Ovature trial | Wed, 15 Apr 2009 |
| Glycotex on Boardroom Radio | Thu, 9 Apr 2009 |
| Glycotex trial achieves accelerated wound closure | Wed, 8 Apr 2009 |
| Appendix 3B | Wed, 1 Apr 2009 |
| Apendix 3X | Wed, 25 Mar 2009 |
| Board changes at Novogen Limited | Mon, 23 Mar 2009 |
| Triphendiol has acceptable safety profile in animals | Thu, 19 Mar 2009 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.



















